10 - 12 February 2014, Conference, Philadelphia, US
10 - 12 February 2014
This conference examines a number of challenges regarding biosimilars including commercial, regulatory, and technical. It will discuss the current commercial trends, what the commercial impact of these new drugs is, and what is happening in the emerging BRIC countries.
It also looks at the latest global regulatory guidelines and issues surrounding biosimilars and what this means for data exclusivity.
Organiser: Paradigm Global Events